ARCHIVES

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Administration Seeks Increase In FDA Budget.

June 13, 2008

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

In Brief: Edwards Takes A Parting Shot At Cancer Program; “Forward Plan” Calls For Emphasis On Prevention

January 17, 1975

Adamson, Henney Chair Silicone Task Force

April 25, 1992

NCI Programs: Institute To Contact For Software To Control Ultrasound Imaging

November 19, 1999